Mutations in exon 8 of TP53 are associated with shorter survival in patients with advanced lung cancer

Currently, in clinical settings, all TP53 mutations have been considered equally. However, numerous studies have demonstrated that the position and type of mutation have differential effects on prognosis. Such discrepancy can be partially due to the lack of unifying classification system for TP53 mu...

Descripción completa

Detalles Bibliográficos
Autores principales: Liu, Yutao, Xu, Fang, Wang, Yubo, Wu, Qingchen, Wang, Buhai, Yao, Yanwen, Zhang, Yu, Han-Zhang, Han, Ye, Junyi, Zhang, Lu, Mao, Xinru, Zhang, Zhe, Liu, Jing, Zhu, Liangjun, Guo, Renhua
Formato: Online Artículo Texto
Lenguaje:English
Publicado: D.A. Spandidos 2019
Materias:
Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6676404/
https://www.ncbi.nlm.nih.gov/pubmed/31452792
http://dx.doi.org/10.3892/ol.2019.10625

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6676404/
https://www.ncbi.nlm.nih.gov/pubmed/31452792
http://dx.doi.org/10.3892/ol.2019.10625

Ejemplares similares